Abacavir and Gliclazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abacavir (abacavir sulfate) and Gliclazide (gliclazide). Common drug interactions include blood bilirubin increased among females and aggression among males.

The phase IV clinical study analyzes what interactions people have when they take Abacavir and Gliclazide. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Abacavir?

Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

On Jul, 14, 2026

11 people who take Abacavir and Gliclazide together, and have interactions are studied.

Abacavir and Gliclazide drug interactions.

What are the common drug interactions of Abacavir and Gliclazide, by gender? *:

female:

Blood bilirubin increased
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Hepatic enzyme increased
Hepatotoxicity (chemical-driven liver damage)
Hypomania (a mild form of mania, marked by elation and hyperactivity)
Jaundice cholestatic
Nausea (feeling of having an urge to vomit)
Orthopnoea (shortness of breath (dyspnea) when lying down)

male:

Aggression
Neutropenia (an abnormally low number of neutrophils)
Diarrhoea
Dysarthria (speech disorder)
Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Gait disturbance
Vomiting
White blood cell count decreased
Psychotic disorder
Drug level increased

What are the common drug interactions of Abacavir and Gliclazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Aggression
Psychotic disorder
Neutropenia (an abnormally low number of neutrophils)
Drug level increased
Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
Therapeutic response decreased (less preventive response)
White blood cell count decreased

50-59:

n/a

60+:

Vomiting
Blood bilirubin increased
Orthopnoea (shortness of breath (dyspnea) when lying down)
Pneumonia
Psychotic disorder
Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
Acute myocardial infarction (acute heart attack)
Blood amylase increased
Blood glucose increased
Chest discomfort

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 45.45%
Psychotic Disorder: 4 people, 36.36%
Affective Disorder (mental disorder): 3 people, 27.27%
Stress And Anxiety: 3 people, 27.27%
Sleep Disorder: 3 people, 27.27%
Blood Pressure Abnormal: 3 people, 27.27%
High Blood Cholesterol: 3 people, 27.27%
Weight Decreased: 2 people, 18.18%
Hypomania (a mild form of mania, marked by elation and hyperactivity): 1 person, 9.09%
Nausea (feeling of having an urge to vomit): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Abacavir and Gliclazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously